Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03502746
Title Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Arkadiusz Z. Dudek, MD
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.